Close Menu

NEW YORK (360Dx) – Chembio Diagnostics today announced it has received Brazilian health agency approval for its DPP Dengue point-of-care system in collaboration with Bio-Manguinhos, a Brazilian government agency and supplier of diagnostic products to the country's Ministry of Health.

Approval for the dengue test — which came from Brazilian health regulator Agência Nacional de Vigilância Sanitária (ANVISA) — is important "considering that the number of dengue cases in Brazil tripled compared to last year," John Sperzel, Chembio’s CEO, said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.